Skip to content

Decoding Your Lab Results

Last updated:

Diagnosing Wilson disease requires piecing together a combination of tests evaluated through the Leipzig Scoring System. Key diagnostics include blood tests like serum ceruloplasmin, 24-hour urinary copper collections, slit-lamp eye exams, and ATP7B genetic testing.

Key Takeaways

  • The Leipzig Scoring System combines your symptoms and test results into a single score to determine the likelihood of Wilson disease.
  • Serum ceruloplasmin and 24-hour urinary copper are primary lab tests used to detect abnormal copper processing in the body.
  • A specialized slit-lamp eye exam is used by an ophthalmologist to look for Kayser-Fleischer rings, a strong indicator of the disease.
  • Genetic testing looks for mutations in the ATP7B gene to definitively confirm a Wilson disease diagnosis.
  • The Relative Exchangeable Copper (REC) test is a newer blood test that measures toxic, unbound copper and may reduce the need for a liver biopsy.

Diagnosing Wilson disease is rarely as simple as a single blood test. Because symptoms can mimic so many other conditions, doctors must piece together a “diagnostic puzzle” using several different types of information [1][2].

The Leipzig Score: Your Diagnostic Roadmap

To make sense of all the different tests, specialists use a tool called the Leipzig Scoring System [3]. This system assigns points based on your symptoms and lab results.

  • Score of 4 or more: Diagnosis of Wilson disease is highly likely [4][5].
  • Score of 2 to 3: Diagnosis is possible, and more testing is needed [4].
  • Score of 0 to 1: Wilson disease is unlikely [4].

The points come from several categories, including the presence of eye rings, neurological symptoms, and the lab tests described below [1][6].

Key Diagnostic Tests

Here are the primary tools used to build your diagnosis and what you should look for on your lab reports.

1. Serum Ceruloplasmin

Ceruloplasmin is a protein that carries copper in your blood [7].

  • The Goal: In most people with Wilson disease, this level is low (typically below 0.2 g/L) [8].
  • The Catch: This test is not perfect. About 15% of patients have normal levels [9]. Levels can also be falsely high due to pregnancy, oral contraceptives, or even a recent infection [10][11].

2. 24-Hour Urinary Copper

This test measures how much copper your body is trying to flush out through your urine over a full day [1].

  • The Goal: High levels (usually more than double the normal limit) are a strong indicator of the disease [8].
  • The Catch: It is very easy to mess up this collection. If you miss even one trip to the bathroom, or if the container used is contaminated with trace metals, the results can be wrong. Practical Tips: Always use a ‘toilet hat’ to easily catch all urine, ensure the collection jug remains cool (like in a cooler with ice), and use only the specialized copper-free jug provided by your lab [12][13].

3. Slit-Lamp Eye Exam

This is not a standard vision test. An ophthalmologist uses a specialized microscope called a slit-lamp to look for Kayser-Fleischer rings in the cornea of your eye [14][15]. These rings are a “smoking gun” for Wilson disease, though they aren’t found in every patient [16].

4. Genetic Testing (ATP7B)

Doctors look at your DNA for mutations in the ATP7B gene [2].

  • The Goal: Finding two “pathogenic” (disease-causing) mutations confirms the diagnosis [17].
  • The Catch: There are over 700 known mutations for this gene [18]. Sometimes, testing finds a “variant of uncertain significance” (VUS) [18]. Do not panic if you see a VUS on your report; it simply means scientists haven’t gathered enough evidence yet to classify that specific gene change as harmless or disease-causing.

5. Liver Biopsy

For many patients—especially those with liver issues and borderline lab results—a liver biopsy is the cornerstone of diagnosis [19][6]. A tiny piece of liver tissue is taken to measure the dry weight of copper. A reading of more than 250 micrograms of copper per gram of dry tissue strongly indicates Wilson disease [6].

6. Relative Exchangeable Copper (REC)

This is a newer, highly accurate blood test that measures the “toxic” fraction of copper—the copper that isn’t bound safely to proteins [20][21]. While liver biopsies are highly reliable, REC is increasingly used to confirm diagnoses and track treatment progress without needing an invasive procedure [22][6].

Your Completeness Checklist

If you are still in the process of being diagnosed, ensure your medical team has performed or scheduled the following:

  • [ ] Serum Ceruloplasmin blood test
  • [ ] 24-Hour Urinary Copper (using a copper-free container)
  • [ ] Slit-lamp exam by an ophthalmologist
  • [ ] Genetic testing (ATP7B mutation analysis)
  • [ ] Liver Biopsy (for hepatic copper quantification, if other tests are inconclusive)
  • [ ] Brain MRI (if you have any neurological or mood symptoms) [23]
  • [ ] Liver function tests (ALT, AST, Bilirubin) [19]

Once your diagnosis is confirmed, your next step is determining how to remove the excess copper. Learn about your options in Your Path to Balance: Treatment Options.

Frequently Asked Questions

What is the Leipzig Score for Wilson disease?
The Leipzig Scoring System is a diagnostic tool doctors use to assign points based on your symptoms and lab test results. A score of 4 or higher indicates that a Wilson disease diagnosis is highly likely.
Why might my serum ceruloplasmin be normal if I have Wilson disease?
While most people with Wilson disease have low ceruloplasmin, about 15 percent of patients have normal levels. Additionally, your levels can appear falsely elevated due to pregnancy, the use of oral contraceptives, or a recent infection.
How do I properly do a 24-hour urine copper collection?
You must collect all of your urine over a full 24-hour period using a specialized copper-free jug provided by your lab. It is critical to catch every drop, keep the collection container cool, and avoid contamination to ensure accurate results.
What does a variant of uncertain significance (VUS) mean on my ATP7B genetic test?
A VUS means that a change was found in your DNA, but scientists do not yet have enough evidence to determine if it causes disease or is completely harmless. Your doctor will use other tests, like urine copper or a liver biopsy, to clarify your diagnosis.
What is the Relative Exchangeable Copper (REC) test?
The REC test is a highly accurate blood test that measures the toxic fraction of copper that is not safely bound to proteins in your blood. It is increasingly used to confirm diagnoses and track treatment progress without needing an invasive liver biopsy.

Questions for Your Doctor

  • What is my current Leipzig score, and which tests contributed the most points to it?
  • Can we calculate my 'Relative Exchangeable Copper' (REC) to see the level of toxic copper in my blood?
  • How did my ceruloplasmin levels compare to the typical reference range for someone my age?
  • Since I am a woman, could my use of oral contraceptives (if applicable) have skewed my ceruloplasmin results?
  • What did the genetic testing show—do I have two known pathogenic mutations, or are they 'variants of uncertain significance'?

Questions for You

  • Did I follow the 24-hour urine collection instructions exactly, including keeping it cool and using a copper-free container?
  • Was my eye exam performed by an ophthalmologist using a slit-lamp microscope specifically to look for Kayser-Fleischer rings?
  • Do I have copies of all my lab reports so I can track my levels over time?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Efficacy of Different Diagnostic Test for Identifying Wilson's Disease.

    Sonia ZF, Rukunuzzaman M, Karim MB, et al.

    Mymensingh medical journal : MMJ 2022; (31(1)):117-123.

    PMID: 34999690
  2. 2

    ATP7B Mutation Analysis: Wilson Disease, A Difficult to Diagnose Case.

    Hashmi MA, Zubaida B, Asghar RM, Lodhi MA

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2020; (30(4)):433-434 doi:10.29271/jcpsp.2020.04.433.

    PMID: 32513368
  3. 3

    Wilson's Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition.

    Socha P, Janczyk W, Dhawan A, et al.

    Journal of pediatric gastroenterology and nutrition 2018; (66(2)):334-344 doi:10.1097/MPG.0000000000001787.

    PMID: 29341979
  4. 4

    Wilson's Disease: Diagnosis of Wilson's Disease in Ethiopian Young Sisters.

    Bekele N, Ewnetu F, Hailu T, et al.

    Case reports in medicine 2020; (2020()):7650170 doi:10.1155/2020/7650170.

    PMID: 32774387
  5. 5

    Diagnosis of Wilson disease.

    Ferenci P

    Handbook of clinical neurology 2017; (142()):171-180 doi:10.1016/B978-0-444-63625-6.00014-8.

    PMID: 28433100
  6. 6

    [Recommendations from the European Association for the Study of the Liver and the European Reference Network for Rare Liver Diseases Clinical Practice Guidelines for hepatolenticular degeneration].

    Tang S, Hou W, Zheng SJ

    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2025; (33(10)):988-992 doi:10.3760/cma.j.cn501113-20250408-00130.

    PMID: 41167770
  7. 7

    Structures of the human Wilson disease copper transporter ATP7B.

    Yang GM, Xu L, Wang RM, et al.

    Cell reports 2023; (42(5)):112417 doi:10.1016/j.celrep.2023.112417.

    PMID: 37074913
  8. 8

    Biomarkers for diagnosis of Wilson's disease.

    Ryan A, Nevitt SJ, Tuohy O, Cook P

    The Cochrane database of systematic reviews 2019; (2019(11)) doi:10.1002/14651858.CD012267.pub2.

    PMID: 31743430
  9. 9

    Hepatic Manifestations in Wilson's Disease: Report of 110 Cases.

    Lin L, Wang D, Ding N, Zheng C

    Hepato-gastroenterology 2015; (62(139)):657-60.

    PMID: 26897948
  10. 10

    Wilson's Disease Update: An Indian Perspective.

    Bhattacharya K, Thankappan B

    Annals of Indian Academy of Neurology 2022; (25(1)):43-53 doi:10.4103/aian.aian_1070_21.

    PMID: 35342245
  11. 11

    Genetically Confirmed Wilson Disease: A Retrospective Cohort Study From Bahrain.

    Isa HM, Alahmed FA, Busehail MY, et al.

    Cureus 2024; (16(10)):e71805 doi:10.7759/cureus.71805.

    PMID: 39559689
  12. 12

    False elevations in urinary metanephrines: under-recognised pitfall with 24-hour urinary volume collection.

    Shin T, Hoang TD, Plunkett MT, Shakir MKM

    BMJ case reports 2021; (14(2)) doi:10.1136/bcr-2020-241147.

    PMID: 33541972
  13. 13

    Accuracy and Usefulness of Select Methods for Assessing Complete Collection of 24-Hour Urine: A Systematic Review.

    John KA, Cogswell ME, Campbell NR, et al.

    Journal of clinical hypertension (Greenwich, Conn.) 2016; (18(5)):456-67 doi:10.1111/jch.12763.

    PMID: 26726000
  14. 14

    Anterior segment optical coherence tomography (AS-OCT) as a new method of detecting copper deposits forming the Kayser-Fleischer ring in patients with Wilson disease.

    Broniek-Kowalik K, Dzieżyc K, Litwin T, et al.

    Acta ophthalmologica 2019; (97(5)):e757-e760 doi:10.1111/aos.14009.

    PMID: 30635971
  15. 15

    Anterior segment optical coherence tomography to look for Kayser-Fleischer rings.

    Sridhar MS, Pineda R

    Practical neurology 2017; (17(3)):222-223 doi:10.1136/practneurol-2017-001605.

    PMID: 28270445
  16. 16

    Kayser-Fleischer rings: The pathognomonic for Wilson's disease.

    Singh P, Subedi B, Mahato D, Karn M

    Clinical case reports 2024; (12(3)):e8642 doi:10.1002/ccr3.8642.

    PMID: 38464582
  17. 17

    Familial screening of children with Wilson disease: Necessity of screening in previous generation and screening methods.

    Li H, Liu L, Li Y, et al.

    Medicine 2018; (97(27)):e11405 doi:10.1097/MD.0000000000011405.

    PMID: 29979436
  18. 18

    The dilemma to diagnose Wilson disease by genetic testing alone.

    Stättermayer AF, Entenmann A, Gschwantler M, et al.

    European journal of clinical investigation 2019; (49(8)):e13147 doi:10.1111/eci.13147.

    PMID: 31169307
  19. 19

    [Wilson's disease or hepatolenticular degeneration].

    Mensing B, Nowak A, Zweifel S, et al.

    Therapeutische Umschau. Revue therapeutique 2018; (75(4)):241-248 doi:10.1024/0040-5930/a000995.

    PMID: 30468117
  20. 20

    Relative exchangeable copper: A highly specific and sensitive biomarker for Wilson disease diagnosis.

    Djebrani-Oussedik N, Desjardins C, Obadia MA, et al.

    JHEP reports : innovation in hepatology 2025; (7(10)):101537 doi:10.1016/j.jhepr.2025.101537.

    PMID: 40980162
  21. 21

    New tools for Wilson's disease diagnosis: exchangeable copper fraction.

    Woimant F, Djebrani-Oussedik N, Poujois A

    Annals of translational medicine 2019; (7(Suppl 2)):S70 doi:10.21037/atm.2019.03.02.

    PMID: 31179307
  22. 22

    EASL-ERN Clinical Practice Guidelines on Wilson's disease.

    Journal of hepatology 2025; doi:10.1016/j.jhep.2024.11.007.

    PMID: 40089450
  23. 23

    Generalized Dystonia as Presenting Feature of Wilson Disease: A Case Report.

    Anushree A, Kumar S, Bhattacharya P, et al.

    Global pediatric health 2023; (10()):2333794X231163418 doi:10.1177/2333794X231163418.

    PMID: 36992844

This page explains Wilson disease diagnostic tests for educational purposes only. Always consult your hepatologist, neurologist, or medical geneticist for professional interpretation of your specific lab results.

Stay up to date

Get notified when new research about Wilson disease is published.

No spam. Unsubscribe anytime.